These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27604939)

  • 1. R&D: Antibiotic partners promote discovery.
    Bakken JS
    Nature; 2016 Sep; 537(7619):167. PubMed ID: 27604939
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 3. Partners in discovery.
    Fuyuno I
    Nature; 2018 Mar; 555(7697):S60. PubMed ID: 29565400
    [No Abstract]   [Full Text] [Related]  

  • 4. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 5. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 6. Leveraging public private partnerships to innovate under challenging budget times.
    Portilla LM; Rohrbaugh ML
    Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target small firms for antibiotic innovation.
    Hwang TJ; Carpenter D; Kesselheim AS
    Science; 2014 May; 344(6187):967-9. PubMed ID: 24876477
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: How to encourage more diagnostics for infectious diseases.
    Powers JH
    BMJ; 2016 Sep; 354():i4744. PubMed ID: 27604999
    [No Abstract]   [Full Text] [Related]  

  • 9. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 10. Executive summary: global antimicrobial resistance alerts and implications.
    Alliance for the Prudent Use of Antibiotics
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S221-3. PubMed ID: 16032555
    [No Abstract]   [Full Text] [Related]  

  • 11. Broken drug markets in infectious diseases: Opportunities outside the private sector?
    Alpern JD; Dunlop SJ; Stauffer WM
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007190. PubMed ID: 30973876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding industry partnerships through an accelerated business engagement program.
    Seeley RJ; Witbeck G; Mulholland MW
    Surgery; 2019 Aug; 166(2):143-146. PubMed ID: 29803564
    [No Abstract]   [Full Text] [Related]  

  • 13. Informatics for neglected diseases collaborations.
    Bost F; Jacobs RT; Kowalczyk P
    Curr Opin Drug Discov Devel; 2010 May; 13(3):286-96. PubMed ID: 20443162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report calls for $2bn global fund to kickstart antibiotic development.
    Wise J
    BMJ; 2015 May; 350():h2635. PubMed ID: 25975228
    [No Abstract]   [Full Text] [Related]  

  • 15. The drug push.
    Servick K
    Science; 2015 May; 348(6237):850-3. PubMed ID: 25999488
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug development partnerships look set to grow.
    Watts G
    Lancet; 2016 Jul; 388(10039):16-8. PubMed ID: 27397780
    [No Abstract]   [Full Text] [Related]  

  • 17. The innovative medicines initiative: a case study for new ways of working in drug R&D.
    Laverty H; Goldman M
    Future Med Chem; 2014 Apr; 6(5):489-91. PubMed ID: 24649951
    [No Abstract]   [Full Text] [Related]  

  • 18. Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive Policy.
    Outterson K; McDonnell A
    Health Aff (Millwood); 2016 May; 35(5):784-90. PubMed ID: 27140983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobials.
    Walsh CT; Wright GD
    Curr Opin Microbiol; 2009 Oct; 12(5):473-5. PubMed ID: 19733112
    [No Abstract]   [Full Text] [Related]  

  • 20. Speeding new antibiotics to market: a fake fix?
    Doshi P
    BMJ; 2015 Mar; 350():h1453. PubMed ID: 25814536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.